Vertex Pharmaceuticals Prepaid & Other Current increased by 20.3% to $853.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 28.2%, from $665.70M to $853.30M. Over 5 years (FY 2020 to FY 2025), Prepaid & Other Current shows an upward trend with a 22.6% CAGR.
Significant changes usually reflect timing differences in vendor payments or shifts in short-term operational requirements.
Payments made in advance for goods or services to be received within one year, along with other miscellaneous short-term...
Usually a small percentage of total assets for tech hardware firms, though it can spike during major production ramp-ups.
prepaid_and_other_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $498.76M | $457.83M | $545.80M | $491.50M | $549.50M | $726.90M | $553.50M | $468.70M | $476.90M | $540.20M | $623.70M | $511.10M | $575.40M | $449.20M | $665.70M | $642.80M | $652.30M | $709.40M | $853.30M |
| QoQ Change | — | -8.2% | +19.2% | -9.9% | +11.8% | +32.3% | -23.9% | -15.3% | +1.7% | +13.3% | +15.5% | -18.1% | +12.6% | -21.9% | +48.2% | -3.4% | +1.5% | +8.8% | +20.3% |
| YoY Change | — | — | — | — | +10.2% | +58.8% | +1.4% | -4.6% | -13.2% | -25.7% | +12.7% | +9.0% | +20.7% | -16.8% | +6.7% | +25.8% | +13.4% | +57.9% | +28.2% |